Case 3

Case 3

 

MCQ’s

 

1. During anaesthesia, a patient with Parkinson’s disease on levodopa should not receive:

 

A enflurane

 

B fentanyl

 

C morphine

 

D droperidol

 

E nitrous oxide

 

 

2. Extrapyramidal effects can be seen following the administration of:

 

A. chlorpropamide

 

B. terfenadine

 

C. metoclopramide

 

D. domperidone

 

E. perphenazine

 

 

3. Recognised causes of abnormal movements of the hands include:

 

A. respiratory failure

 

B. renal failure

 

C. chronic alcoholism

 

D. liver failure

 

E. depigmentation of substantia nigra

 

 

4. Oral drugs which can be used in the treatment of Parkinson’s disease as first line agents are:

 

A. entacapone

 

B. Levodopa

 

C. Selegiline

 

D. Apomorphine

 

E. pethidine

 

 

5. Recognised features of Parkinson’s disease are:

 

A. rigidity

 

B. dry mouth

 

C. orthostatic hypotension

 

D. dysphagia

 

E. restrictive ventilatory defect

 

Answers to MCQ’s

 

· FFFTF

 

· FFTTT

 

· TFTTT

 

· FTTFF – Levodopa and selegiline can be used orally as single agents to treat Parkinson’s disease. Entacapone is used in conjunction with levodopa- DDI. Pethidine should not be used in patients on MAO type B inhibitors.

 

· TFTTT – rigidity is a feature of PD. PD results in excess saliva/ sialorrhoea. Orthostatic hypotension can be due to PD itself, or due to the effects of dopaminergic or anticholinergic agents used in PD. Respiratory muscle rigidity may result in a restrictive ventilatory defect.